BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1344672)

  • 1. Setting health-based residue limits for contaminants in pharmaceuticals and medical devices.
    Conine DL; Naumann BD; Hecker LH
    Qual Assur; 1992 Jun; 1(3):171-80. PubMed ID: 1344672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acrylamide, antiparasitic agents, dioxins and more: how dangerous are contaminants and residues in food?].
    Hamscher G
    Dtsch Tierarztl Wochenschr; 2004 Jul; 111(7):288-91. PubMed ID: 15366289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dietary risk assessment for pesticide residues in food of plant origin during the plant protection product's registration process].
    Struciński P; Góralczyk K; Czaja K; Hernik A; Korcz W; Ludwicki JK
    Rocz Panstw Zakl Hig; 2006; 57(4):303-15. PubMed ID: 17713193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Background to the ADI/TDI/PTWI.
    Herrman JL; Younes M
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S109-13. PubMed ID: 10597623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations regarding a permitted daily exposure calculation for ethyl methanesulfonate.
    Müller L; Gocke E
    Toxicol Lett; 2009 Nov; 190(3):330-2. PubMed ID: 19857798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate.
    Hasegawa R; Koizumi M; Hirose A
    Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity.
    Müller L; Mauthe RJ; Riley CM; Andino MM; Antonis DD; Beels C; DeGeorge J; De Knaep AG; Ellison D; Fagerland JA; Frank R; Fritschel B; Galloway S; Harpur E; Humfrey CD; Jacks AS; Jagota N; Mackinnon J; Mohan G; Ness DK; O'Donovan MR; Smith MD; Vudathala G; Yotti L
    Regul Toxicol Pharmacol; 2006 Apr; 44(3):198-211. PubMed ID: 16412543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limits for pesticide residues in infant foods: a safety-based proposal.
    Schilter B; Renwick AG; Huggett AC
    Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):126-40. PubMed ID: 8933626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision of estimates of an ADI (or TDI or PTWI).
    Speijers GJ
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Consumer risk assessment in case of maximum residue levels (MRLs) violations in food].
    Struciński P; Góralczyk K; Czaja K; Hernik A; Korcz W; Ludwicki JK
    Rocz Panstw Zakl Hig; 2007; 58(2):377-88. PubMed ID: 17929585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of antimicrobial residues on gut communities: are the new regulations effective?
    Silley P
    J Appl Microbiol; 2007 May; 102(5):1220-6. PubMed ID: 17448157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedures for calculating benchmark doses for health risk assessment.
    Gaylor D; Ryan L; Krewski D; Zhu Y
    Regul Toxicol Pharmacol; 1998 Oct; 28(2):150-64. PubMed ID: 9927564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary exposure of Brazilian consumers to dithiocarbamate pesticides--a probabilistic approach.
    Caldas ED; Tressou J; Boon PE
    Food Chem Toxicol; 2006 Sep; 44(9):1562-71. PubMed ID: 16777311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics.
    Singh-Joy SD; McLain VC
    Int J Toxicol; 2008; 27 Suppl 2():93-128. PubMed ID: 18830866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity testing and derivation of the ADI.
    Walker R
    Food Addit Contam; 1998; 15 Suppl():11-6. PubMed ID: 9602908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method for calculating ADI-derived guidance values for drug carryover levels in medicated feeds.
    Nestmann ER; Lynch BS
    Regul Toxicol Pharmacol; 2007 Apr; 47(3):232-9. PubMed ID: 17150293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the U.S. Army's health risk assessments for oral exposure to six chemical-warfare agents. Introduction.
    J Toxicol Environ Health A; 2000 Mar; 59(5-6):281-526. PubMed ID: 10742829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.